Vaylen vs Sprout Health: Prepay Pricing vs Fast Approval
Vaylen vs Sprout Health pits a prepaid, low-rate compounded GLP-1 plan against a fast-entry provider with a first-month discount. Early verdict: Vaylen centers on low annualized rates and a refund if a clinician declines, while Sprout Health focuses on lightning-quick approval and a $50 first-month discount.
How they differ at a glance
The most distinctive differences between Vaylen and Sprout Health are billing and pricing structure, treatment formats offered, approval speed and onboarding friction, refund and prepaid terms, and outcome framing. Below we compare these points directly using only supplied evidence.
Billing and price structure
Vaylen publishes annualized 12-month rates billed upfront: semaglutide injections from $83.25/mo (billed as $999), oral semaglutide $99/mo, and tirzepatide $149/mo. Vaylen emphasizes you pay before a clinician reviews your file, with a stated full refund for that billing cycle if a clinician declines. Sprout Health offers a $50 off first month promotion that brings the initial cost to $199, with ongoing pricing at $249/month; its ongoing rate is higher than several competitors according to the source. Sprout Health does not present prepaid 12-month pricing in the supplied evidence.
Get Sprout Health first-month offer
Treatment formats and molecules
Vaylen sells compounded GLP-1 in three formats and two molecules on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide. The source states that both molecules and a needle-free format are available so a clinician can switch formats without changing providers. Sprout Health is presented as a telehealth GLP-1 platform prescribing compounded semaglutide; the evidence highlights outcome framing but does not list the same breadth of formats as Vaylen.
Choose Vaylen for multiple formats
Approval speed and onboarding friction
Sprout Health emphasizes a “lightning-quick approval” process and positions itself for patients who want a fast, low-friction entry to GLP-1 therapy. Vaylen reports clinician review within 24 hours but requires prepayment before the clinician sees your file, creating a different onboarding tradeoff where speed and a published refund are paired with prepaying a full year.
Refunds, cancellations, and shipping
Vaylen states free discreet shipping in 1 to 3 business days, $0 consultation fee, cancel anytime, and a published full refund if a clinician declines to prescribe for that billing cycle. Vaylen also notes no published terms for the unused portion of a prepaid year if you cancel mid-treatment. Sprout Health’s captured page does not verify shipping, fees, membership, or cancellation terms in the supplied evidence beyond the first-month discount and pricing schedule.
Outcome framing and regulatory notes
Sprout Health frames potential outcomes as 10 to 26% body weight loss in 12 months and uses that outcome-focused messaging in marketing. Vaylen references average weight-loss figures tied to the molecules it sells on its pages but the comparison evidence emphasizes Vaylen’s pricing and format choices. Both providers’ supplied evidence includes a regulatory note that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality.
Side-by-side comparison
| Criteria | Vaylen | Sprout Health |
|---|---|---|
| Starting price | $83.25/mo on 12-month semaglutide plan (annualized) | $199 first month after $50 off; $249/month ongoing |
| Billing model | Prepaid 12-month plans billed upfront; pay before clinician review | Monthly billing with first-month discount |
| Formats offered | Injectable semaglutide, oral semaglutide tablet, tirzepatide injectable | Compounded semaglutide via telehealth (formats not fully listed) |
| Approval speed | Clinician review within 24 hours after prepay | Lightning-quick approval after intake |
| Refunds / cancellations | Full refund for that billing cycle if clinician declines; no published unused-year terms | Not verified on captured page |
| Shipping | Free discreet shipping in 1 to 3 business days | Shipping not verified on captured page |
| Regulatory note | Compounded medications are not FDA-approved finished products | Compounded medications are not FDA-approved finished products |
Which one should you choose?
Choose Vaylen if you are confident prefunding a 12-month compounded GLP-1 plan to access lower annualized rates, want access to injectable and oral semaglutide plus tirzepatide on one platform, and value a published full refund if a clinician declines. Choose Sprout Health if you prioritize lightning-quick approval and a low-friction start with a $50 first-month discount and accept a higher ongoing monthly price.
Start Sprout Health with $50 off
In summary, Vaylen vs Sprout Health is a tradeoff between prepaid low annualized pricing, multiple formats, and a refund-if-declined policy at Vaylen, versus Sprout Health’s speed, clear outcome framing, and an initial $50 discount. Use the distinctions above to match the provider to your priorities and consult each platform’s clinician review process to confirm eligibility and treatment details.